Remove Diagnose Remove Disease Remove Radiation Remove Radiation Oncology
article thumbnail

Dr. Sameer Keole voted President-elect of the American Society for Radiation Oncology (ASTRO)

Imaging Technology

milla1cf Thu, 07/20/2023 - 20:11 July 20, 2023 — The members of the American Society for Radiation Oncology ( ASTRO ) recently elected three new officers to ASTRO’s Board of Directors, including Sameer Keole , MD, FASTRO , as President-elect; Wendy Woodward , MD, PhD, FASTRO, as Science Council Vice Chair; and Vivek S.

article thumbnail

Widespread Staff Shortages Exacerbate Pressures Facing Radiation Oncology Clinics; ASTRO Advocacy Day Calls for Action

Imaging Technology

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASTRO updates guidelines for treating throat cancer

AuntMinnie

The American Society for Radiation Oncology (ASTRO) has released updated guidelines on the use of radiation therapy in patients with oropharyngeal squamous cell carcinoma (OPSCC) caused by HPV. They also cover treatment planning and response assessment for patients diagnosed with this type of head and neck cancer.

article thumbnail

ASTRO: IMRT and proton therapy equally effective for prostate cancer

AuntMinnie

Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting. each year – are diagnosed as localized disease.

article thumbnail

SBRT as Effective as Conventional Radiation for People with Intermediate Risk, Localized Prostate Cancer

Imaging Technology

milla1cf Fri, 09/29/2023 - 17:00 September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

article thumbnail

ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

Imaging Technology

The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor.

article thumbnail

Liquid Biopsy May Help Identify Which Patients with Non-small Cell Lung Cancer Will Benefit Most from Radiation

Imaging Technology

milla1cf Mon, 10/02/2023 - 13:30 October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests. and worldwide. and worldwide.